Spravato Esketamine Nasal Spray

Get a Price/Quote

Spravato Esketamine Nasal Spray Specification

Indication
For intranasal use only as prescribed by a physician

Salt Composition
Esketamine

Brand Name
Spravato

Life Span
Shelf life not specified on the package

Dosage Form
Nasal spray

Origin of Medicine
Not specified on the visible packaging

Pacakaging (Quantity Per Box)
2 nasal spray devices (28 mg each)

Drug Type
Prescription medicine

Ingredients
(esketamine) is a prescription nasal spray used with an oral antidepressant to treat adults with treatment-resistant depression or major depressive disorder with active suicidal thoughts Active Ingredient: It uses esketamine, a chemical related to ketamine. Brain Target: It blocks NMDA receptors in the brain to help form new neural connections. Fast Relief: It can reduce depressive symptoms much faster than traditional daily pills.

Physical Form
Nasal Spray

Function

Recommended For
Patients prescribed Esketamine for depression or other medical indications as advised by a physician

Dosage
56 mg Dose Kit (Two 28 mg Nasal Spray Devices)

Dosage Guidelines
For intranasal use only; use as directed by healthcare provider

Suitable For
Adults only, for intranasal use

Quantity
2 nasal spray devices per kit

Storage Instructions
Refer to package insert or physicians direction (storage conditions not specified on visible packaging)

Kit Contents
Two single-use nasal spray devices

Mode of Administration
Intranasal

Therapeutic Class
Antidepressant (NMDA receptor antagonist)

Dose Strength
56 mg total per kit

Patient Advisory
For use under medical supervision only

Barcode
3 50458 02802 7

Prescription Status
Prescription Only Medicine (Schedule CIII)

Spravato Esketamine Nasal Spray About

(esketamine) is a prescription nasal spray used with an oral antidepressant to treat adults with treatment-resistant depression or major depressive disorder with active suicidal thoughts

How Spravato Works for Depression

Spravato (esketamine) provides a breakthrough option for individuals with depression that has not responded to standard treatments. By blocking NMDA receptors in the brain, esketamine helps promote the formation of new neural pathways, which can offer rapid symptom relief. This innovative approach addresses major depressive disorder and provides hope for patients needing faster and more effective results.

Usage and Administration Process

Spravato is administered intranasally in a medical setting under the supervision of trained healthcare professionals. Each kit contains two nasal spray devices (28 mg esketamine each) for a total 56 mg dose. Your provider will instruct you on dosage frequency and post-administration monitoring, ensuring the highest safety standards during each visit. Never use Spravato unsupervised at home.

Benefits of Esketamine Nasal Spray

Patients prescribed Spravato may benefit from a faster reduction in depressive symptoms compared to traditional oral antidepressants. The medication's targeted mechanism offers significant improvement for adults with major depressive disorder or treatment-resistant depression. Regular use as directed by your provider can help regain daily functioning and overall mental well-being.

FAQ's of Spravato Esketamine Nasal Spray:

Q: How is Spravato Esketamine Nasal Spray administered?

A: Spravato is administered intranasally using two single-use nasal spray devices per kit for a total 56 mg dose. The treatment is provided in a healthcare setting under medical supervision to ensure safety.

Q: What are the primary benefits of using Spravato?

A: Spravato can deliver a much faster reduction in depressive symptoms compared to traditional antidepressant pills. It is especially intended for adults with treatment-resistant depression or major depressive disorder with active suicidal ideation.

Q: When should Spravato be used?

A: Spravato is prescribed when standard oral antidepressants have not been effective for major depressive disorder or for patients experiencing severe suicidal thoughts. Administration and timing are determined by your healthcare provider.

Q: Where should I receive Spravato treatment?

A: Spravato must always be administered in a certified medical facility, such as a hospital or clinic, under the supervision of healthcare professionals. It is not meant for at-home use.

Q: What is the process for receiving a Spravato dose?

A: Each Spravato session involves using two single-use nasal spray devices, delivering 28 mg each, for a total dose of 56 mg. After the medication is administered, patients are monitored for a period as directed by their provider for safety.

Q: Who is eligible to use Spravato Esketamine Nasal Spray?

A: Spravato is recommended for adults diagnosed with major depressive disorder or treatment-resistant depression who have not responded to other antidepressant therapies. Suitability is determined by a physician.

Q: How should Spravato be stored?

A: Storage instructions are included in the package insert or provided by your healthcare provider. Always follow professional guidelines for proper handling and storage details.

Tell us about your requirement